Biotechnology

News

The bureaucracy blocking the chance at a cure
Writingruxandrabio.com

How early-stage clinical trials became unnecessarily expensive and inefficient—and how we can fix them, inspired by a recent story about a dog treated for cancer. more…

Hidden deep-sea proteins could supercharge disease tests
Science Daily

Hidden in volcanic lakes and deep-sea vents, scientists have discovered tough new DNA-binding proteins built to survive extreme conditions. After scanning huge genetic databases, researchers found molecules that remain stable under heat, salt, and harsh chemi… more…

A donut-shaped protein breaks apart to start bacterial cell division
Science Daily

Researchers have revealed how bacteria precisely control the genes that trigger cell division. The study shows that the MraZ protein, which normally forms a donut-shaped structure, must bend and partially break apart to bind key DNA sequences that activate di… more…

Can weight-loss pills replace injectables? What the science says
Nature.com

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages. more…

Daily briefing: Vaccine-carrying mosquitoes could inoculate bats against rabies
Nature.com

New technique aims to prevent bats from spreading disease, the science behind health supplements and the ‘same-ifying’ effect of writing with AI. more…

Daily briefing: Funding calls plummet as NIH turns away from agency-directed science
Nature.com

The US National Institutes of Health will now focus on ‘unsolicited’ research proposals driven by the interests of individual scientists. Plus, the oldest known recording of a whale’s song and how tiny electric vehicles can help to change the world. more…

Top brass in China reaffirm goal to be world leaders in tech, AI
Nature.com

The new five-year plan calls for more original scientific research to facilitate the country's bid for self-reliance. more…

Daily briefing: How labs are coping with ‘RAMmageddon’
Nature.com

A global shortage of memory chips is forcing researchers to get creative. Plus, China’s plans to become the global tech leader and the AI arms race unfolding in lecture halls. more…

US’s new scramble for Africa is biomedical imperialism
Al Jazeera English

From Zimbabwe to Zambia, US health deals are raising fears of a new era of biomedical extractivism. more…

BTech in Bioengineering vs BTech in Biosciences and Bioengineering: What should I choose?
The Indian Express

BTech in Bioengineering vs BTech in Biosciences and Bioengineering: While the academic pathways may differ slightly, both fields contribute to solving major challenges in healthcare, sustainability and biotechnology. more…

Mushroom biotech startups help address global challenges
Nature.com

This Review article explores how startups translate advances in mycology, biotechnology and biofabrication to address pressing environmental and societal challenges. It positions mushrooms as a cross-sector platform for sustainable innovation with wide-reachi… more…

Dynamics of phage-host interactions in Bacteroides fragilis resolved by single-cell transcriptomics
Nature.com

Phage-bacteria interactions are typically studied in bulk culture, which obscures cell-cell differences. Here the authors study phage-bacteria interactions using single-cell transcriptomics, identifying cell subpopulations that resist infection through variab… more…

The University as Idea Factory
Inside Higher Ed

The University as Idea Factory Sara Brady Mon, 03/16/2026 - 03:00 AM In a world of limited resources, where government funding is core to our business model, we must justify our existence to skeptics. Byline(s) John Kroger more…

Balenciaga debuts eight-legged yarns
Nature.com

Nature Biotechnology - Balenciaga debuts eight-legged yarns more…

A bridge recombinase for human genome editing
Nature.com

Nature Biotechnology - A bridge recombinase for human genome editing more…

FDA backpedals to review Moderna mRNA flu vaccine
Nature.com

Nature Biotechnology - FDA backpedals to review Moderna mRNA flu vaccine more…

Broadly protective mucosal vaccine harnesses integrated immunity
Nature.com

Nature Biotechnology - Broadly protective mucosal vaccine harnesses integrated immunity more…

Biotech news from around the world
Nature.com

Nature Biotechnology - Biotech news from around the world more…

BBB Hunter agent nears FDA decision
Nature.com

Nature Biotechnology - BBB Hunter agent nears FDA decision more…

In vivo base editing reverses a neurodevelopmental disorder
Nature.com

Nature Biotechnology - In vivo base editing reverses a neurodevelopmental disorder more…

New rules spur cell and gene therapy trials in China
Nature.com

Nature Biotechnology - New rules spur cell and gene therapy trials in China more…

USP7 facilitates brain tumor survival upon glucose deprivation by regulating phosphofructokinase muscle-type nuclear translocation in mice
Plos.org

We discover a novel function of PFKM in promoting glioma cell survival under glucose deficiency by switching metabolism from glycolysis to FAO. Upon GD, the levels of F-2,6-BP are decreased, leading to the enhanced interaction between USP7 and PFKM. USP7 then… more…

How the classic computer game Doom became a tool for science
Nature.com

The 1990s game has been run on bacteria and a satellite and played by neurons in a dish. more…

Daily briefing: Genomes shake up the shark family tree
Nature.com

Is there no such thing as a shark? Plus, the role of videogame icon Doom in science and how people with a religious connection to glaciers are responding to their loss. more…

Daily briefing: China approves world-first brain–computer interface device
Nature.com

A brain implant can help people with severe paralysis to move their hands. Plus, a US court has blocked RFK Jr’s attempt to rewrite the country’s vaccine recommendations and a call from the chief exec of Microsoft AI to stop programming chatbots to hijack hum… more…

Adaptive evolution of gene regulatory networks in mammalian neocortex
Nature.com

The excitatory neuron diversity and specialized connectivity of complex, multilayered mammalian neocortex are driven by mammalian-specific cis-regulatory elements bound by ZBTB18, deletion of which disrupts gene expression and results in projection patterns r… more…

Synthetic circuits for cell ratio control
Nature.com

A synthetic genetic circuit made up of recombinase-based cell-fate branching devices enables precise control over the ratios of cell types in an offspring population derived from one founder strain, and could be used to build user-defined multicellular aggreg… more…

The E3 ubiquitin ligase mechanism specifying targeted microRNA degradation
Nature.com

Target-directed microRNA degradation is driven by the atypical ZSWIM8–CUL3 E3 ubiquitin ligase that uses a two-RNA-factor authentication mechanism to specifically recognize AGO–miRNA–trigger RNA complexes and polyubiquitylate AGO. more…

Russians could get free personalized cancer vaccines
RT

The Russian government plans to cover treatment with new cancer vaccines under the national health insurance system Read Full Article at RT.com more…

nvidia plans to make all unstructured data structured
Next Big Future

Nvidia will structure hundreds of zettabytes per year of unstructured data to make it the ground truth for AI. AI will created value from that data. Nvidia will have confidential computing. Even the operator will not see the data more…

SpaceX Testing Booster for V3 Starship Launch in 3-4 Weeks
Next Big Future

Super Heavy booster has been ready to continue preflight testing for 5 days and has been testing. SpaceX is conducting a series of tests to activate Pad 2 at Starbase, exercise new propellant loading operations, and operate a vehicle with new Raptor 3 engines… more…

US Destroys All Military Targets on Kharg Island Which Is Iran’s Oil Export Hub
Next Big Future

The has struck all military targets on Kharg Island in the last 2 hours or so. Moments ago, at my direction, the United States Central Command executed one of the most powerful bombing raids in the History of the Middle East, and totally obliterated every MIL… more…

GAMECHANGER BIGGER THAN TESLA ROBOTAXI ? AI Bombshell
Next Big Future

Elon Musk dropped huge news that changes everything. 7GWs of data center that would be 5 times bigger than XAI colossus and would keep growing faster. Accredited Investors can sign up for educational discussion and Q&A with Brian Wang. Tesla and XAI digital o… more…

All Organic Building Blocks of Life Likely Form Naturally in Space
Next Big Future

Organic molecules delivered from extraterrestrial materials may have played a key role in supplying building blocks for life on Earth. Scientists have found all five canonical nucleobases—purines (adenine and guanine) and pyrimidines (cytosine, thymine and ur… more…

Nvidia GTC 2026 Preshow. Jensen Next
Next Big Future

The pre show is done. Which had Gavin Baker and Alfred Lin. And many CEO of Robotaxi and AI companies The AI YouTuber and venture capitalist who headed up (or co-hosted/led) the NVIDIA GTC preshow is Sara Guo the GTC Pregame Live with Alfred Lin (Sequoia part… more…

Elon Musk 8 Times Richer Than Bill Gates
Next Big Future

Bill Gates is down to 19th richest person in the world. He has a little more than three times as much as his x-wife. Bill has one eighths of the wealth of Elon Musk. Bill got out of Microsoft shares and into railroads and conservative mostly non-tech investme… more…

X US Admiral Describes Two Week Plan for US Victory
Next Big Future

x-Admiral Montgomery’s sees a 2-3 week timeline to US control of Hormuz. Conditions must be set for control, if they are not set then it will very difficult to end the war. The degradation strikes continue (including on all the island sites) could reach the k… more…

Nvidia GTC Highlights – Nvidia Goal to Make All Data Ground Truth for AI
Next Big Future

Jensen Huang GTC 2026 Keynote Highlights (March 16, 2026) NemoClaw Launch NVIDIA unveiled NemoClaw, an enterprise-ready, secure version of OpenClaw (open-source AI agents platform). This is the enterprise ready OpenSource form of Openclaw. Openclaw is by some… more…

Optimus and AI Abundance and Recursive AI Improvement is Here Already
Next Big Future

Elon Musk says Optimus 3 (teslabot) is essentially complete and will be by far the most advanced robot in the world. Nothing’s even close. The production start is the Summer 2026. It will be a very slow/low-volume ramp initially. There will be high-volume pro… more…

SpaceX Space AI Ramp
Next Big Future

SpaceX + xAI integration/merger will power humanity’s first Dyson swarm orbital solar-powered AI data centers. Orbital/space-based compute is a no-brainer because of constant sunlight and vacuum cooling—no terrestrial energy or land constraints. Elon Musk cou… more…

Ford Has a Few Million Additional Recalls – Not Yet at Recall Death Spiral
Next Big Future

Ford has three separate issues requiring recalls. They affect more than 2.3 million of its SUVs in all, including models from Lincoln, the Blue Oval’s luxury brand. Ford has issued 18 recalls so far in 2026 affecting 7.4 million vehicles and one tiny engine-b… more…

Blockchain ecosystems are expanding into global sports industries
Next Big Future

Web3 infrastructure and professional athletics never appeared to be a match in the early days of crypto, but they’ve proven to be a match made in heaven. It began as a niche interest in digital collectibles, hosted on the sports blockchain, but has since turn… more…

Nvidia Structured Data is the Ground Truth of AI – $120 Billion Structure Data Ecosystem
Next Big Future

Nvidia has a structured data enablement strategy. Nvidia provides libaries, software and hardware to index and search data faster. The Indexing and retrievals are way faster 10-40X faster in most cases. How cuDF + cuVS Work Together (The GTC 2026 “Ground Trut… more…

Severe COVID or flu may raise lung cancer risk years later
Science Daily

A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumor… more…

Mind Wars: How 5GW, mind control and biotech are enslaving humanity
Naturalnews.com

Modern warfare has shifted from physical battlefields to psychological and technological manipulation (5GW). Tactics include social media algorithms, directed energy weapons (DEWs) and bioweapons (e.g., mRNA vaccines) designed for control, not healing. COVID-… more…

제놀루션, 공동대표 김민이 장내 자사주 3만주 추가 매입
Venturesquare.net

그린바이오 전문기업 제놀루션이 김민이 공동대표이사가 장내에서 자사주 3만주를 매입했다고 공시했다. 이번 매입은 책임경영과 주주가치 제고 의지를 보여주는 조치로 평가되며, 회사는 분자진단과 RNA 기반 그린바이오 사업 확장을 지속할 계획이다. The post 제놀루션, 공동대표 김민이 장내 자사주 3만주 추가 매입 appeared first on 벤처스퀘어. more…

제이앤피메디, ‘제약산업기술거래센터 26차년도 기술거래위원회 위원’ 선임
Venturesquare.net

제이앤피메디의 나현희 부사장과 이성경 센터장이 제약산업기술거래센터 26차년도 기술거래위원회 위원으로 위촉됐다. 두 임원은 회사의 임상 전략, 사업개발, 규제 대응 전문성을 기반으로 기술거래 활동에 참여하며, 제약·바이오 기업 간 협력과 기술 사업화 확대에 기여할 예정이... The post 제이앤피메디, ‘제약산업기술거래센터 26차년도 기술거래위원회 위원’ 선임 appeared first on 벤처스퀘어. more…

뉴패러다임인베스트먼트, 키움증권과 IPO 전략 세미나 개최
Venturesquare.net

뉴패러다임인베스트먼트가 키움증권과 함께 포트폴리오 기업을 대상으로 IPO 전략 세미나를 열고 상장 준비에 필요한 시장 동향과 제도 변화, 실무 이슈 등을 공유했다. 이번 세미나는 초기 투자 이후 기업 성장과 상장까지 이어지는 지원 체계를 강화하기 위해 마련됐다. The post 뉴패러다임인베스트먼트, 키움증권과 IPO 전략 세미나 개최 appeared first on 벤처스퀘어. more…

Middle East conflict disrupts supply chains, Taiwan materials maker flags rare force majeure notices
Digitimes

Shinkong Synthetic Fibers Corporation (SSFC) is accelerating its transformation into AI, semiconductors, biotechnology, and optical films, positioning itself as an advanced materials supplier for next-generation industries. more…

Highly accurate ab initio gene annotation with ANNEVO
Nature.com

ANNEVO advances accurate and scalable ab initio gene annotation of evolutionarily diverse genomes using deep learning approach modeling sequence evolution and long-range dependencies and mixture of experts (MoE) architecture. more…

READ IN FULL: Rachel Reeves’ Brexit-Bashing Mais Lecture
Order-order.com

Read the full 7563-word lecture by going to the bottom of this page. Here’s the summary for those afraid of falling asleep at the desk: Brexit Said Brexit “did deep damage”, citing GDP impacts of “up to 8%“. Regulatory independence should be “the exception, n… more…

Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds
MarketBeat

Certara (NASDAQ:CERT) executives used a discussion at the Leerink Partners global healthcare conference to outline recent performance, the assumptions behind... more…

Connecting across continents with women of Cisco Networking Academy
Cisco.com

Through Cisco Networking Academy, millions of learners each year gain the skills and credentials they need to lead, create, and thrive in the tech industry. Here, we’re showcasing a few of Cisco Networking Academy's inspiring women and their unique career jou… more…

InnoEX och Hong Kong Electronics Fair (Spring Edition) öppnar i april 2026
Nyteknik.se

Visar banbrytande lösningar inom AI, robotik, låghöjdsekonomi, smarta hem, hälsoteknik med mera. more…

A novel planctomycetotal isolate from subsurface percolates belongs to the novel species Anatilimnocola aquadivae sp. nov. in the family Pirellulaceae
Nature.com

The family Pirellulaceae (phylum Planctomycetota) is known for its environmental versatility, with members isolated from marine habitats, algal surfaces, soil and lakes; yet, no member has been isolated from terrestrial subsurface habitats. Here, we describe … more…

Inside the Gen Z Shark Tank where influencers are becoming venture investors
Fortune

Why Bulletpitch is bringing together content creators and startup founders. more…

What Happens When Employers Co-Design the Cybersecurity Classroom
Edsurge.com

When high school students step into a cybersecurity internship, they enter a field where the stakes are real. The tools, threats and responsibilities ... more…

Nucleosome positioning shapes cryptic antisense transcription
Plos.org

Author summary Cells must control where transcription begins so that genes are expressed accurately. Yet RNA polymerase can also start from hidden sites within genes and produce antisense RNAs from the opposite DNA strand. Antisense transcription is common ac… more…

COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function
Plos.org

Author summary COG5, a subunit of the Conserved Oligomeric Golgi (COG) complex, is critical for maintaining Golgi structure and function. While its established role in glycosylation explains some congenital disorders, the full spectrum of associated pathologi… more…

Scrap NYSC if you can’t protect corpers, parents tell FG
The Punch

Parents urge the Federal Government to scrap the NYSC scheme if it cannot guarantee the safety of corps members amid rising kidnappings and attacks. Read More: https://punchng.com/scrap-nysc-if-you-cant-protect-corpers-parents-tell-fg/ more…

"CNBC Cures: Defying Rare Disease" with Becky Quick to Premiere on Thursday, March 19 at 7PM ET
Thefutoncritic.com

The special spotlights the families dealing with rare diseases and the scientists, advocates, and innovators fighting to change their futures. more…

Robert Pattinson’s Dune 3 Villain Explained: Everything To Know About Scytale
ComicBook.com

The trailer for Dune: Part Three has finally dropped, sending fans of one of the biggest sci‑fi sagas into a frenzy. But even before that moment arrived, excitement for the film was already through the roof, especially because of the new characters. So far, w… more…

Energy opens applications for $293 million in research funding
Nextgov

A new RFA invites scientific researchers to apply for federal funding to solve pressing scientific and technological challenges and advance the Genesis Mission. more…

ENMOD: Dodo, Dormant or Presciently Divine?
Opiniojuris.org

[Vanessa Murphy and Helen Obregón Gieseken are Legal Advisers at the Legal Division of the International Committee of the Red Cross (ICRC) in Geneva] At the 34th International Conference of the Red Cross and Red Crescent in October 2024, Nigeria and European … more…

Jünger aussehen mit 60? Diese Lebensmittel machen den Unterschied
Abendblatt.de

Wie man sich in jungen Jahren ernährt, kann sich später im Gesicht zeigen. Welche Lebensmittel Sie im Alter jünger aussehen lassen, verrät unsere Expertin. more…

Prenuvo CEO bets he can save lives and major healthcare spending by ‘inverting the pyramid’
New York Post

"MRI is the most accurate imaging modality for our organs, but it's the last thing you're ever given," Andrew Lacy told NYNext. His company offer an alternative. more…

Drip by drip, learn the Israeli way
The Times of India

India is looking to Israel for agricultural advancements. Israel transformed desert land into a productive farming nation using technology. India faces similar challenges like water scarcity and low productivity. Collaboration can boost India's farm output an… more…

Designing diphosphines towards photo- and electro-luminescent homoleptic Cu(I)/Ag(I) complexes
Royal Society of Chemistry

J. Mater. Chem. C, 2026, Advance ArticleDOI: 10.1039/D6TC00433D, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Sophia Lipinski, Thomas Pickl, Youssef Atoini, Stefano Sansotta, Jean-Louis Schmitt, Lu… more…

ICAR to build national gender platform linking 900 institutions to boost women's role in farming
BusinessLine

The conference, attended by delegates from 18 countries, concluded with the adoption of the Delhi Declaration, which calls for establishing a Global Alliance on Women in Agri-Food Systems more…

Iran war has US farmers worried about the cost and availability of fertilizer
Abcnews.com

Farmers are bracing for effects of the Iran war on fertilizer prices and availability as the spring planting season nears more…

Pharmaceuticals and Biotechnology Manufacturing and Supply Agreements Analysis Report 2026
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026" report has been added to ResearchAndMarkets.com's offering.The Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology r… more…

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
GlobeNewswire

FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming … more…

Pharmaceuticals and Biotechnology Clinical Stage Partnering Terms and Agreements Trends Report 2026: Detailed Upfront, Milestone and Royalty Structures, Contract Records and Top Partnering Profiles
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering. more…

Pharmaceuticals and Biotechnology Preclinical Stage Partnering Terms and Agreements Report 2026 with Directory of 1,750 Deals Signed Since 2020 by Company, Phase, Therapeutic Area, and Technology
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering. more…

Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Agreements Trends Report 2026 with Directory of 384 Deal Records - Terms, Structures, and Strategies Behind These Impactful Partnerships
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2026" report has been added to ResearchAndMarkets.com's offering. more…

Pharmaceutical and Biotechnology Royalty Rates Agreements Report and Directory 2026: Insights Into 1,567 Licensing Transactions by Company A-Z, Therapeutic Area, Technology, Headline Value
GlobeNewswire

This report is tailored for C-level executives, business development professionals, licensing managers, legal advisors, and anyone involved in pharmaceutical and biotechnology deal-making. It provides the tools needed to evaluate and negotiate royalty terms e… more…

Pharmaceuticals and Biotechnology Co-development Agreements Report 2026: Review Headline Values, Milestone Payments, and Equity Contributions
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026" report has been added to ResearchAndMarkets.com's offering.The Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 report d… more…

Pharmaceuticals and Biotechnology Asset Purchase Agreements Report 2026 and Directory of Deals Signed Since 2019 by the World's Leading Life Science Companies
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering.The Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026 report prov… more…

Pharmaceuticals and Biotechnology Distribution Agreements Report 2026: How Companies Structure Distribution Agreements, Negotiate Financial Terms, and Allocate Commercialization Responsibilities
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering.This latest Distribution Deals in Pharmaceuticals and Biotechnology report provides a… more…

Biotechnology Licensing Agreements Trends Report 2026 with Directory of 2,500+ Deals Signed Since 2020 by the World's Leading Biopharma Companies
GlobeNewswire

Fully revised and updated, the report provides detailed information on 2,500+ biotechnology licensing deals announced between 2020 and 2026, offering a broad view of licensing activity across emerging technologies and therapeutic areas. Each transaction inclu… more…

$11.65 Bn Synthetic Spider Silk Markets, 2026-2035 Industry Trends and Global Forecasts
GlobeNewswire

The synthetic spider silk market offers significant growth opportunities in defense, automotive, aerospace, textiles, and healthcare, driven by advancements in production and biotechnology. Asia leads in market share, bolstered by strong demand in automotive … more…

Saudi Arabia Synthetic Biology Market Trends and Forecasts Report 2026-2035: CRISPR Innovation, Collaborations, Genomic Tools and Food Security Initiatives Spur Expansion
GlobeNewswire

Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by investing in CRISPR, bioengineering for food production in … more…

Biotechnology Collaboration Agreements Report 2026 with Directory of 2,000+ Deals Signed Since 2020 - Access Real Contract Documents and Identify the Most Active Dealmakers
GlobeNewswire

Fully revised and updated, the report includes 2,096 collaboration deals announced between 2020 and 2026, offering an extensive view of partnering activity across the biotechnology landscape. Each deal record includes financial information where available and… more…

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
GlobeNewswire

SAN DIEGO, March 12, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented on its proprietary manufacturing pr… more…

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
GlobeNewswire

PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric lysosomal storage disorders (“LSDs”), today announced that the U.S. Foo… more…

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
Financial Post

Cambridge, Massachusetts, March 18, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announc… more…

Equillium to Participate in the 38th Annual Roth Conference
GlobeNewswire

LA JOLLA, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat … more…

Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
GlobeNewswire

TAMPA, Fla. and LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating payloads, today announced its abstract has been ac… more…

Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
GlobeNewswire

WALTHAM, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that it will implement… more…

Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
GlobeNewswire

BOSTON, March 12, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today reported financial results… more…

FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
GlobeNewswire

HOUSTON, March 12, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic dis… more…

Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
Financial Post

VICTORIA, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize … more…

Odisha unveils roadmap to accelerate blue economy
The Times of India

Odisha is charting a course to become a national leader in the blue economy, leveraging its extensive coastline. A new roadmap, unveiled at a global summit, focuses on port-led urbanisation and developing industrial hubs near key ports. The state aims to attr… more…

Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
GlobeNewswire

MALVERN, Pa., March 16, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzhei… more…

Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
GlobeNewswire

BERKELEY HEIGHTS, N.J., March 17, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company, today announced an oral presentation and two poster presentations o… more…

Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire

WALTHAM, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced an upcoming poster pre… more…

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
GlobeNewswire

CORAL GABLES, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announ… more…

Pharmaceuticals and Biotechnology Option and Evaluation Agreements Report 2026 with Directory of Deals Signed Since 2019 by Company A-Z, Therapeutic Area, Technology Type, and Industry Sector
GlobeNewswire

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering.The Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-20… more…

Organoids and Spheroids Market to Reach USD 11.94 Billion by 2035, Propelled by Surging Demand for Advanced 3D Cell Culture Models and Precision Medicine Expansion – SNS Insider
GlobeNewswire

Integration of CRISPR Gene Editing, AI-Based Drug Screening, and Patient-Derived Organoid Platforms Reshaping Biomedical Research and Pharmaceutical Drug Discovery Globally. Integration of CRISPR Gene Editing, AI-Based Drug Screening, and Patient-Derived Orga… more…

Stocks

Agilent Technologies, Inc.
Alexion Pharmaceuticals, Inc.
Amgen Inc.
Biogen Inc.
Celgene Corporation
Gilead Sciences, Inc.
Illumina, Inc.
Incyte Corporation
Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated
Galapagos NV
ACADIA Pharmaceuticals Inc.
Accelerate Diagnostics, Inc.
Acceleron Pharma Inc.
Achieve Life Sciences, Inc.
Achillion Pharmaceuticals, Inc.
Acorda Therapeutics, Inc.
Adaptimmune Therapeutics plc
ADMA Biologics Inc
Aduro Biotech, Inc.
Advaxis, Inc.
Adverum Biotechnologies, Inc.
AEterna Zentaris Inc.
Aevi Genomic Medicine, Inc.
Affimed N.V.
Agenus Inc.
Agios Pharmaceuticals, Inc.
Aimmune Therapeutics, Inc.
Akebia Therapeutics, Inc.
Alder BioPharmaceuticals, Inc.
Aldeyra Therapeutics, Inc.
Alimera Sciences, Inc.
Alkermes plc
Alliqua BioMedical, Inc.
Alnylam Pharmaceuticals, Inc.
Alpine Immune Sciences, Inc.
AMAG Pharmaceuticals, Inc.
Amicus Therapeutics, Inc.
AnaptysBio, Inc.
Anavex Life Sciences Corp.
Applied Genetic Technologies Corporation
Aptevo Therapeutics Inc.
Aptose Biosciences, Inc.
AquaBounty Technologies, Inc.
Aquinox Pharmaceuticals, Inc.
Arbutus Biopharma Corporation
ARCA biopharma, Inc.
Ardelyx, Inc.
Arena Pharmaceuticals, Inc.
Array BioPharma Inc.
Arrowhead Pharmaceuticals, Inc.
Ascendis Pharma A/S
Atara Biotherapeutics, Inc.
Athersys, Inc.
aTyr Pharma, Inc.
Audentes Therapeutics, Inc.
Aurinia Pharmaceuticals Inc
Auris Medical Holding AG
AVEO Pharmaceuticals, Inc.
Axovant Sciences Ltd.
AzurRx BioPharma, Inc.
BeiGene, Ltd.
Bellicum Pharmaceuticals, Inc.
Benitec Biopharma Limited
Bioblast Pharma Ltd.
Biocept, Inc.
BioCryst Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Bio-Path Holdings, Inc.
Bio-Techne Corp
bluebird bio, Inc.
Blueprint Medicines Corporation
Calithera Biosciences, Inc.
Capricor Therapeutics, Inc.
Cara Therapeutics, Inc.
CareDx, Inc.
CASI Pharmaceuticals, Inc.
Catabasis Pharmaceuticals, Inc.
Catalyst Biosciences, Inc.
Celldex Therapeutics, Inc.
Cellect Biotechnology Ltd.
Cellectar Biosciences, Inc.
Cellectis S.A.
Cellular Biomedicine Group, Inc.
Champions Oncology, Inc.
ChemoCentryx, Inc.
Chiasma, Inc.
Chimerix, Inc.
China Biologic Products Holdings, Inc.
Cidara Therapeutics, Inc.
Cleveland BioLabs, Inc.
Clovis Oncology, Inc.
Co-Diagnostics, Inc.
CohBar, Inc.
Coherus BioSciences, Inc.
Compugen Ltd.
Conatus Pharmaceuticals Inc.
Concert Pharmaceuticals, Inc.
ContraFect Corporation
Corbus Pharmaceuticals Holdings, Inc.
Corium International, Inc.
CRISPR Therapeutics AG
Curis, Inc.
Cyclacel Pharmaceuticals, Inc.
CymaBay Therapeutics Inc.
Cytokinetics, Incorporated
CytomX Therapeutics, Inc.
Cytori Therapeutics Inc
Dare Bioscience, Inc.
DBV Technologies S.A.
Deciphera Pharmaceuticals, Inc.
Dermira, Inc.
Dicerna Pharmaceuticals, Inc.
Diffusion Pharmaceuticals Inc.
Dynavax Technologies Corporation
EDAP TMS S.A.
Edge Therapeutics, Inc.
Editas Medicine, Inc.
Eiger BioPharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc.
Endocyte, Inc.
ENDRA Life Sciences Inc.
Epizyme, Inc.
Erytech Pharma S.A.
Esperion Therapeutics, Inc.
Evofem Biosciences, Inc.
Evogene Ltd.
Exact Sciences Corporation
Exelixis, Inc.
Fate Therapeutics, Inc.
Fennec Pharmaceuticals Inc.
Fibrocell Science Inc
FibroGen, Inc
Five Prime Therapeutics, Inc.
Flexion Therapeutics, Inc.
Fortress Biotech, Inc.
Forward Pharma A/S
Galectin Therapeutics Inc.
Genetic Technologies Ltd
Genocea Biosciences, Inc.
Genomic Health, Inc.
Geron Corporation
Global Blood Therapeutics, Inc.
GlycoMimetics, Inc.
GTx, Inc.
Halozyme Therapeutics, Inc.
Harvard Bioscience, Inc.
Heat Biologics, Inc.
Heron Therapeutics, Inc.
Histogenics Corporation
HTG Molecular Diagnostics, Inc.
Idera Pharmaceuticals, Inc.
Immune Design Corp.
ImmunoGen, Inc.
Immunomedics, Inc.
Immuron Limited
Immutep Limited
Infinity Pharmaceuticals, Inc.
Insmed, Inc.
Insys Therapeutics, Inc.
Intellia Therapeutics, Inc.
Intellipharmaceutics International Inc.
Intra-Cellular Therapies Inc.
InVivo Therapeutics Holdings Corp.
Ionis Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc.
Jounce Therapeutics, Inc.
Kamada Ltd.
Karyopharm Therapeutics Inc.
Kazia Therapeutics Limited
Keryx Biopharmaceuticals, Inc.
Kura Oncology, Inc.
La Jolla Pharmaceutical Company
LEAP THERAPEUTICS, INC.
Lexicon Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated
Loxo Oncology, Inc.
Luminex Corporation
MacroGenics, Inc.
MannKind Corporation
MediciNova, Inc.
Meridian Bioscience Inc.
Merrimack Pharmaceuticals, Inc.
Mersana Therapeutics, Inc.
Merus N.V.
Mesoblast Limited
Microbot Medical Inc.
Midatech Pharma PLC
MiMedx Group, Inc
Minerva Neurosciences, Inc
Miragen Therapeutics, Inc.
Mirati Therapeutics, Inc.
Molecular Templates, Inc.
Momenta Pharmaceuticals, Inc.
Motif Bio plc
Myriad Genetics, Inc.
Nabriva Therapeutics plc
NanoString Technologies, Inc.
NantKwest, Inc.
Natera, Inc.
Nektar Therapeutics
Neptune Technologies & Bioresources Inc
Neuralstem, Inc.
Neurocrine Biosciences, Inc.
NewLink Genetics Corporation
Novavax, Inc.
Novelion Therapeutics Inc.
NuCana plc
Ohr Pharmaceuticals, Inc.
Omeros Corporation
Oncobiologics, Inc.
OncoMed Pharmaceuticals, Inc.
Onconova Therapeutics, Inc.
OpGen, Inc.
Ophthotech Corporation
Opiant Pharmaceuticals, Inc.
Opko Health, Inc.
Organovo Holdings, Inc.
Otonomy, Inc.
OvaScience Inc.
Pacific Biosciences of California, Inc.
Paratek Pharmaceuticals, Inc.
PDL BioPharma, Inc.
Pieris Pharmaceuticals, Inc.
Pluristem Therapeutics, Inc.
Prana Biotechnology Ltd
Precipio, Inc.
Progenics Pharmaceuticals Inc.
ProQR Therapeutics N.V.
Protagonist Therapeutics, Inc.
Proteon Therapeutics, Inc.
Proteostasis Therapeutics, Inc.
Prothena Corporation plc
PTC Therapeutics, Inc.
Pulmatrix, Inc.
Puma Biotechnology Inc
Radius Health, Inc.
Recro Pharma, Inc.
Redhill Biopharma Ltd.
REGENXBIO Inc.
Repligen Corporation
Retrophin, Inc.
Rhythm Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc.
RTI Surgical, Inc.
RXi Pharmaceuticals Corporation
Sangamo Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Savara, Inc.
Seattle Genetics, Inc.
Selecta Biosciences, Inc.
SELLAS Life Sciences Group, Inc.
SenesTech, Inc.
Seres Therapeutics, Inc.
Sierra Oncology, Inc.
Sinovac Biotech, Ltd.
Soligenix, Inc.
Sophiris Bio, Inc.
Sorrento Therapeutics, Inc.
Spark Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.
Stellar Biotechnologies, Inc.
Stemline Therapeutics, Inc.
Strongbridge Biopharma plc
Summit Therapeutics plc
Sunesis Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc.
Synlogic, Inc.
Syros Pharmaceuticals, Inc.
T2 Biosystems, Inc.
TESARO, Inc.
TG Therapeutics, Inc.
Therapix Biosciences Ltd.
Titan Pharmaceuticals, Inc.
Tocagen Inc.
TRACON Pharmaceuticals, Inc.
Trevena, Inc.
Trillium Therapeutics Inc.
TrovaGene, Inc.
Ultragenyx Pharmaceutical Inc.
uniQure N.V.
UroGen Pharma Ltd.
Vanda Pharmaceuticals Inc.
Vascular Biogenics Ltd.
VBI Vaccines, Inc.
Veracyte, Inc.
Verastem, Inc.
Vermillion, Inc.
Vical Incorporated
Viking Therapeutics, Inc.
VistaGen Therapeutics, Inc.
Vital Therapies, Inc.
Voyager Therapeutics, Inc.
vTv Therapeutics Inc.
WAVE Life Sciences Ltd.
XBiotech Inc.
Xencor, Inc.
Xenetic Biosciences, Inc.
Xenon Pharmaceuticals Inc.
XOMA Corporation
XTL Biopharmaceuticals Ltd.
Zafgen, Inc.
Zai Lab Limited
Zealand Pharma A/S
ZIOPHARM Oncology Inc
Kadmon Holdings, Inc. (KDMN)
Pfenex Inc. (PFNX)
Intrexon Corporation (XON)
Myovant Sciences Ltd. (MYOV)
Monster Digital, Inc. (INNT)
Orgenesis Inc. (ORGS)
AmpliPhi Biosciences Corporation
Asterias Biotherapeutics Inc. Common Series A
Actinium Pharmaceuticals Inc. (Delaware)
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
CollPlant Holdings Ltd.
Cel-Sci Corporation ($0.001 Par Value)
Emergent Biosolutions Inc.
Enzo Biochem Inc. ($0.01 Par Value)
Hemispherx BioPharma Inc.
iBio Inc.
India Globalization Capital Inc.
IsoRay Inc.
Matinas Biopharma Holdings Inc.
Navidea Biopharmaceuticals Inc.
NovaBay Pharmaceuticals Inc.
NanoViricides Inc.
Oragenics Inc.
Palatin Technologies Inc.
Rexahn Pharmaceuticals Inc.
Synthetic Biologics Inc.
Vaxart Inc.
Senesco Technologies Inc. (ELOX)
Sesen Bio, Inc.
Correvio Pharma Corp.
Standard Diversified Inc. Class A
DiaMedica Inc